World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
33947
World Ranking
11670
National Ranking
1109

Overview

Pardeep S. Jhund is affiliated with the University of Glasgow in the United Kingdom. Their research primarily focuses on Medicine, with a specialization in Cardiology and Cardiovascular Medicine. Their work also spans related subfields including Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine, and Molecular Biology.

The scientist's research covers a variety of main topics, notably Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiovascular Function and Risk Factors, Pancreatic function and diabetes, Hormonal Regulation and Hypertension, Cardiac pacing and defibrillation studies, and Blood Pressure and Hypertension Studies.

Among recent publications, their notable papers include:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction, 2022, New England Journal of Medicine
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials, 2022, The Lancet
  • Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials, 2020, The Lancet
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes, 2020, JAMA
  • Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction, 2024, New England Journal of Medicine

Frequently collaborating with other researchers, their main co-authors include:

  • John J.V. McMurray
  • Scott D. Solomon
  • Muthiah Vaduganathan
  • Akshay S. Desai
  • Brian Claggett

Publications are often found in key cardiovascular and medical journals, with high numbers of contributions in:

  • European Journal of Heart Failure
  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal
  • JACC Heart Failure

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    Søren L Kristensen;Søren L Kristensen;Rasmus Rørth;Rasmus Rørth;Pardeep S Jhund;Kieran F Docherty

  • Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people

    Pardeep S. Jhund;Kate MacIntyre;Colin R. Simpson;James D. Lewsey

  • Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

    Nathaniel Mark Hawkins;Mark C. Petrie;Pardeep S. Jhund;George W. Chalmers

  • Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

    Muthiah Vaduganathan;Brian L Claggett;Pardeep S Jhund;Jonathan W Cunningham

  • Declining Risk of Sudden Death in Heart Failure

    Li Shen;Pardeep S. Jhund;Mark C. Petrie;Mark C. Petrie;Brian L. Claggett

  • Changes in diabetes-related complications in the United States.

    Marc A. Pfeffer;Pardeep Jhund;David Aguilar

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

  • Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum

    Lars H. Lund;Brian Claggett;Jiankang Liu;Carolyn S. Lam

  • Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

    Søren L. Kristensen;Søren L. Kristensen;David Preiss;Pardeep S. Jhund;Iain Squire;Iain Squire

  • Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

    Kevin Damman;Mauro Gori;Brian Claggett;Pardeep S. Jhund

  • Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

    Rury R Holman;Ruth L Coleman;Juliana C N Chan;Jean-Louis Chiasson

  • Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.

    John J.V. McMurray;Alice M. Jackson;Carolyn S.P. Lam;Carolyn S.P. Lam;Carolyn S.P. Lam;Margaret M. Redfield

  • Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).

    Matthew M.Y. Lee;Matthew M.Y. Lee;Katriona J.M. Brooksbank;Kirsty Wetherall;Kenneth Mangion

  • Heart failure and socioeconomic status: accumulating evidence of inequality

    Nathaniel M. Hawkins;Pardeep S. Jhund;John J.V. McMurray;Simon Capewell

  • Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

    Mikhail N. Kosiborod;Mikhail N. Kosiborod;Pardeep S. Jhund;Kieran F. Docherty;Mirta Diez

  • A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

    Niamh F. Murphy;Colin Richard Simpson;Pardeep S. Jhund;Pardeep S. Jhund;Simon Stewart

  • Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients.

    Elke Platz;Elke Platz;Eldrin F. Lewis;Eldrin F. Lewis;Hajime Uno;Julie Peck

  • Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.

    Pardeep S. Jhund;Michael Fu;Edmundo Bayram;Chen Huan Chen;Chen Huan Chen

Frequent Co-Authors

John J.V. McMurray
John J.V. McMurray University of Glasgow
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Mark C. Petrie
Mark C. Petrie University of Glasgow
Lars Køber
Lars Køber Copenhagen University Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital
Mikhail Kosiborod
Mikhail Kosiborod University of Missouri–Kansas City
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean attending a traditional medical school. There are several respected online degrees and healthcare career paths that offer flexibility and affordability. For those seeking a leadership role in nursing, consider the best dnp programs online to advance your clinical expertise and impact patient care.

If you're interested in pharmacy, it’s worth comparing online pharmacy school cost to make an informed decision about this competitive field. Alternatively, pursuing a him bachelor's degree online can lead to challenging roles managing patient records and health data.

For those seeking a shorter program with strong job prospects, understanding how much is medical billing and coding school can help you start a healthcare support career quickly and affordably. Each option has unique admission requirements, tuition, and career outcomes to consider as you plan your future in healthcare.

Best Scientists Citing Pardeep S. Jhund

Trending Scientists